ProSciento provides its clients a significant advantage in patient access and enrollment via its PRO PASS™ diagnostic IRB-approved protocol deployed at sites across the nation and growing globally that provides detailed diagnostic data to aid in optimizing inclusion/exclusion (I/E) criteria and site selection based on patients that meet protocol eligibility.
ProSciento considers patient engagement and retention as a critical priority for all studies. Our Patient Recruitment and Retention team creates patient-centric, study-specific plans designed to optimize engagement throughout the patient’s journey in our clients’ studies. Our solutions leverage technology-based innovations, including automated text and email touchpoints, educational resources, and patient concierge services.
